Drugs / Polymerized Human Hemoglobin (Pyridoxylated)
Polymerized Human Hemoglobin (Pyridoxylated)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00076648 | — | — | Northfield Laboratories | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polymerized Human Hemoglobin (Pyridoxylated) | “Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme(R)]” NCT00076648 ↗ |
| Known as | Poly SFH-P | “Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme(R)]” NCT00076648 ↗ |
| Known as | PolyHeme | “Human polymerized hemoglobin (PolyHeme, Northfield Laboratories) is a universally compatible oxygen carrier developed to treat life-threatening anemia.” PMID 19228496 ↗ Nov 2008 |
| Modality | Protein / enzyme biologic | “Human polymerized hemoglobin (PolyHeme, Northfield Laboratories)” PMID 19228496 ↗ Nov 2008 |